A New Drug Target for Type 2 Diabetes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28666114.
- Also identified by DOI 10.1016/j.cell.2017.06.024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genetic studies can identify novel therapeutic targets for common complex diseases. In this issue of Cell, Rusu et al. demonstrate that a cluster of genetic variants associated with an increased risk of type 2 diabetes affect the function of a monocarboxylate transporter involved in nutrient flux and hepatic lipid metabolism.
Medical subject headings
- Diabetes Mellitus, Type 2
- Liver